Evozyne
Chicago
About Evozyne
Evozyne is a generative AI company that focuses on therapeutic discovery and drug development. It is a biotechnology company that specializes in protein design and molecular scale. Its mission is to unlock the potential of novel proteins to solve complex human and societal challenges by revolutionizing protein design. It was founded in 2020 and is headquartered in Chicago, Illinois.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $144.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2023)
- Website: evozyne.com
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/evozyne-7778 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.